Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Otorhinolaryngology

Free Subscription Articles published in Clin Exp Allergy Retrieve available abstracts of 74 articles: HTML format

Single Articles

February 2024
1. SIMARD ML, Novak N, Drolet JP, Joly MC, et al
   Tolerability of sublingual versus vestibular allergy immunotherapy tablet administration: A randomized pilot study.
   Clin Exp Allergy. 2024;54:120-129.
   PubMed     Abstract available
   
   
   January 2024
2. TAN S, Zhou S, Fan K, Jin L, et al
   Bulk and single-cell transcriptome sequencing reveal the metabolic feature in chronic rhinosinusitis with polyps.
   Clin Exp Allergy. 2024;54:67-70.
   PubMed    
   
   
   December 2023
3. VOGELBERG C, Klimek L, Kruppert S, Becker S, et al
   Long-term effects of pollen allergoid tyrosine-adsorbed subcutaneous immunotherapy on allergic rhinitis and asthma.
   Clin Exp Allergy. 2023 Dec 26. doi: 10.1111/cea.14444.
   PubMed     Abstract available
   
   
   
4. LEHTIMAKI J, Gupta S, Hjelmso M, Shah S, et al
   Fungi and bacteria in the beds of rural and urban infants correlate with later risk of atopic diseases.
   Clin Exp Allergy. 2023;53:1268-1278.
   PubMed     Abstract available
   
   
   November 2023
5. WOLFF D, Drewitz KP, Ulrich A, Siegels D, et al
   Allergic diseases as risk factors for Long-COVID symptoms: Systematic review of prospective cohort studies.
   Clin Exp Allergy. 2023;53:1162-1176.
   PubMed     Abstract available
   
   
   
6. BAUER RN, Xie Y, Beaudin S, Wiltshire L, et al
   Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids.
   Clin Exp Allergy. 2023;53:1187-1197.
   PubMed     Abstract available
   
   
   September 2023
7. BUCHHEIT KM, Hacker J, Maurer R, McGill A, et al
   Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.
   Clin Exp Allergy. 2023;53:974-977.
   PubMed    
   
   
   August 2023
8. AHLBECK L, Ahlberg E, Stuivers L, Bjorkander J, et al
   Intralymphatic immunotherapy with birch and grass pollen extracts. A randomized double-blind placebo-controlled clinical trial.
   Clin Exp Allergy. 2023;53:809-820.
   PubMed     Abstract available
   
   
   July 2023
9. MOITRA S, Mahesh PA, Moitra S
   Allergic rhinitis in India.
   Clin Exp Allergy. 2023;53:765-776.
   PubMed     Abstract available
   
   
   
10. LAHA A, Moitra S, Podder S
    A review on aero-allergen induced allergy in India.
    Clin Exp Allergy. 2023;53:711-738.
    PubMed     Abstract available
    
    
    June 2023
11. LEE Y, Kim C, Lee E, Lee HY, et al
    Long-term clinical outcomes of aspirin-exacerbated respiratory disease: Real-world data from an adult asthma cohort.
    Clin Exp Allergy. 2023 Jun 18. doi: 10.1111/cea.14362.
    PubMed     Abstract available
    
    
    
12. GOKTAS P, Can Bostan O, Gulseren D, Cakmak ME, et al
    Thermo-SPT: A new skin prick test evaluation framework based on low-cost, portable smartphone thermography.
    Clin Exp Allergy. 2023;53:626-635.
    PubMed     Abstract available
    
    
    April 2023
13. DUAN S, Han X, Jiao J, Wang M, et al
    Histone deacetylase activity is a novel target for epithelial barrier defects in patients with eosinophilic chronic rhinosinusitis with nasal polyps.
    Clin Exp Allergy. 2023;53:443-454.
    PubMed     Abstract available
    
    
    March 2023
14. MAHESH PA, Moitra S, Mabalirajan U, Garg M, et al
    Allergic diseases in India - Prevalence, risk factors and current challenges.
    Clin Exp Allergy. 2023;53:276-294.
    PubMed     Abstract available
    
    
    February 2023
15. SOUZA DA CUNHA S, Santorelli G, Pembrey L
    Defining cases of asthma, eczema and allergic rhinitis using electronic health records in the Born in Bradford birth cohort.
    Clin Exp Allergy. 2023 Feb 9. doi: 10.1111/cea.14291.
    PubMed    
    
    
    December 2022
16. SHAMJI MH, Boyle RJ
    Mepolizumab for eosinophilic chronic rhinosinusitis, loss of smell and challenges with accessibility to allergen immunotherapy.
    Clin Exp Allergy. 2022;52:1358-1360.
    PubMed    
    
    
    
17. JIANG Z, Xiao H, Zhang H, Jia Q, et al
    Broussonetia papyrifera (paper mulberry) pollen is an important cause of allergic rhinitis in Southwest China.
    Clin Exp Allergy. 2022;52:1448-1451.
    PubMed    
    
    
    
18. VALBERT F, Neusser S, Pfaar O, Klimek L, et al
    Care with allergen immunotherapy for allergic respiratory diseases in Germany-Predictors and deficits.
    Clin Exp Allergy. 2022;52:1422-1431.
    PubMed     Abstract available
    
    
    
19. TCHEKMEDYIAN R, Lundberg M, Buchheit KM, Maurer R, et al
    Loss of smell in patients with aspirin-exacerbated respiratory disease impacts mental health and quality of life.
    Clin Exp Allergy. 2022;52:1414-1421.
    PubMed     Abstract available
    
    
    
20. WALTER S, Ho J, Alvarado R, Smith G, et al
    Mepolizumab decreases tissue eosinophils while increasing type-2 cytokines in eosinophilic chronic rhinosinusitis.
    Clin Exp Allergy. 2022;52:1403-1413.
    PubMed     Abstract available
    
    
    November 2022
21. HWANG IC, Ahn HY
    Oxidative balance in subjects with allergic rhinitis: A nationwide cross-sectional survey.
    Clin Exp Allergy. 2022;52:1347-1350.
    PubMed    
    
    
    
22. ROLLEMA C, van Roon EN, van Boven JFM, Hagedoorn P, et al
    Pharmacology, particle deposition and drug administration techniques of intranasal corticosteroids for treating allergic rhinitis.
    Clin Exp Allergy. 2022;52:1247-1263.
    PubMed     Abstract available
    
    
    
23. BIRS I, Boulay ME, Bertrand M, Cote A, et al
    Heterogeneity of asthma with nasal polyposis phenotypes: A cluster analysis.
    Clin Exp Allergy. 2022 Nov 1. doi: 10.1111/cea.14247.
    PubMed     Abstract available
    
    
    October 2022
24. ANTO A, Sousa-Pinto B, Czarlewski W, Pfaar O, et al
    Automatic market research of mobile health apps for the self-management of allergic rhinitis.
    Clin Exp Allergy. 2022;52:1195-1207.
    PubMed     Abstract available
    
    
    September 2022
25. SKYPALA IJ, Hunter H, Krishna MT, Rey-Garcia H, et al
    BSACI guideline for the diagnosis and management of pollen food syndrome in the UK.
    Clin Exp Allergy. 2022;52:1018-1034.
    PubMed     Abstract available
    
    
    
26. PETERS AT, Soler ZM, Kern RC, Heffler E, et al
    Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials.
    Clin Exp Allergy. 2022;52:1105-1109.
    PubMed    
    
    
    
27. LOPEZ DJ, Lodge CJ, Bui DS, Waidyatillake NT, et al
    Establishing subclasses of childhood eczema, their risk factors and prognosis.
    Clin Exp Allergy. 2022;52:1079-1090.
    PubMed     Abstract available
    
    
    August 2022
28. ERMIS SSO, Borres MP, Basna R, Ekerljung L, et al
    Sensitization to molecular dog allergens in an adult population: Results from the West Sweden Asthma Study.
    Clin Exp Allergy. 2022 Aug 19. doi: 10.1111/cea.14216.
    PubMed     Abstract available
    
    
    
29. STOJANOVIC S, Zubrinich C, Sverrild A, Mahoney J, et al
    Laryngoscopy diagnosis of inducible laryngeal obstruction during supervised challenge for suspected anaphylaxis.
    Clin Exp Allergy. 2022;52:924-928.
    PubMed    
    
    
    
30. EIDE JG, Wu J, Stevens WW, Bai J, et al
    Anti-phospholipid antibodies are elevated and functionally active in chronic rhinosinusitis with nasal polyps.
    Clin Exp Allergy. 2022;52:954-964.
    PubMed     Abstract available
    
    
    
31. SHOKOUHI SHOORMASTI R, Rafaiani C, Fazlollahi MR, Kazemnejad A, et al
    Molecular profile of specific IgE to allergenic components in allergic adults using allergen nano-bead array.
    Clin Exp Allergy. 2022;52:942-953.
    PubMed     Abstract available
    
    
    July 2022
32. PRICE CPE, Guo A, Stevens WW, Cousens L, et al
    Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial.
    Clin Exp Allergy. 2022;52:859-867.
    PubMed     Abstract available
    
    
    
33. GREGORY I, Grewal A
    Cochrane corner: Intranasal corticosteroids for non-allergic rhinitis.
    Clin Exp Allergy. 2022;52:836-838.
    PubMed    
    
    
    
34. BREW BK, Almqvist C, Lundholm C, Andreasson A, et al
    Comorbidity of atopic diseases and gastro-oesophageal reflux: evidence of a shared cause.
    Clin Exp Allergy. 2022;52:868-877.
    PubMed     Abstract available
    
    
    
35. FENG M, Luo T, Xian M, Shi X, et al
    Suppression function against environmental dust exposure after Dermatophagoides pteronyssinus immunotherapy is associated with production of specific and cross-reactive immunoglobulin G4.
    Clin Exp Allergy. 2022;52:878-887.
    PubMed     Abstract available
    
    
    June 2022
36. AHLBECK L, Ahlberg E, Bjorkander J, Alden C, et al
    Intralymphatic immunotherapy with one or two allergens renders similar clinical response in patients with allergic rhinitis due to birch and grass pollen.
    Clin Exp Allergy. 2022;52:747-759.
    PubMed     Abstract available
    
    
    
37. MARTENSSON A, Nordstrom FU, Cervin-Hoberg C, Lindstedt M, et al
    Nasal administration of a probiotic assemblage in allergic rhinitis: A randomised placebo-controlled crossover trial.
    Clin Exp Allergy. 2022;52:774-783.
    PubMed     Abstract available
    
    
    May 2022
38. GILL AS, Alt JA, Pulsipher A, Smith KA, et al
    Topographic distribution of gene expression and sinonasal inflammation in chronic rhinosinusitis without nasal polyposis.
    Clin Exp Allergy. 2022;52:719-722.
    PubMed    
    
    
    
39. MATUCCI A, Nencini F, Maggiore G, Chiccoli F, et al
    High proportion of inflammatory CD62L(low) eosinophils in blood and nasal polyps of severe asthma patients.
    Clin Exp Allergy. 2022 May 1. doi: 10.1111/cea.14153.
    PubMed     Abstract available
    
    
    April 2022
40. SUBIZA J, Cabrera M, Jm CR, Jc C, et al
    Influence of climate change on airborne pollen concentrations in Madrid, 1979-2018.
    Clin Exp Allergy. 2022;52:574-577.
    PubMed    
    
    
    March 2022
41. MAHONEY J, Hew M, Vertigan A, Oates J, et al
    Treatment effectiveness for Vocal Cord Dysfunction in adults and adolescents: A systematic review.
    Clin Exp Allergy. 2022;52:387-404.
    PubMed     Abstract available
    
    
    February 2022
42. BACHERT C, Peters AT, Heffler E, Han JK, et al
    Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 stud
    Clin Exp Allergy. 2022;52:244-249.
    PubMed    
    
    
    
43. YAO Y, Zeng M, Liu Z
    Revisiting Asian chronic rhinosinusitis in the era of type 2 biologics.
    Clin Exp Allergy. 2022;52:231-243.
    PubMed     Abstract available
    
    
    January 2022
44. SIO YY, Shi P, Say YH, Chew FT, et al
    Functional variants in the chromosome 4q21 locus contribute to allergic rhinitis risk by modulating the expression of N-acylethanolamine acid amidase.
    Clin Exp Allergy. 2022;52:127-136.
    PubMed     Abstract available
    
    
    December 2021
45. SCALA E, Caprini E, Abeni D, Meneguzzi G, et al
    A qualitative and quantitative comparison of IgE antibody profiles with two multiplex platforms for component-resolved diagnostics in allergic patients.
    Clin Exp Allergy. 2021;51:1603-1612.
    PubMed     Abstract available
    
    
    
46. JAKWERTH CA, Chaker AM, Guerth F, Oelsner M, et al
    Sputum microRNA-screening reveals Prostaglandin EP3 receptor as selective target in allergen-specific immunotherapy.
    Clin Exp Allergy. 2021;51:1577-1591.
    PubMed     Abstract available
    
    
    August 2021
47. MACGLASHAN D JR, Alvarez-Arango S, Tversky J
    Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels.
    Clin Exp Allergy. 2021;51:1093-1095.
    PubMed    
    
    
    
48. SOARES P, Fidler K, Felton J, Jones CJ, et al
    An FCER2 polymorphism is associated with increased oral leukotriene receptor antagonists and allergic rhinitis prescribing.
    Clin Exp Allergy. 2021;51:1089-1092.
    PubMed    
    
    
    
49. LAM HCY, Jarvis D
    Seasonal variation in total and pollen-specific immunoglobulin E levels in the European Community Respiratory Health Survey.
    Clin Exp Allergy. 2021;51:1085-1088.
    PubMed    
    
    
    
50. BOUSQUET J, Schroder-Bernhardi D, Bachert C, Canonica GW, et al
    Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on MIDAS and OTCims platforms.
    Clin Exp Allergy. 2021;51:1033-1045.
    PubMed     Abstract available
    
    
    July 2021
51. RAMPERSAD A, Banerjee N, Hinks TSC
    Are biologics for chronic rhinosinusitis effective and safe?
    Clin Exp Allergy. 2021;51:870-872.
    PubMed    
    
    
    June 2021
52. MARGARITTE-JEANNIN P, Budu-Aggrey A, Ege M, Madore AM, et al
    Identification of OCA2 as a novel locus for the co-morbidity of asthma-plus-eczema.
    Clin Exp Allergy. 2021 Jun 22. doi: 10.1111/cea.13972.
    PubMed     Abstract available
    
    
    
53. ARASI S, Castelli S, Di Fraia M, Villalta D, et al
    @IT2020: An innovative algorithm for allergen immunotherapy prescription in seasonal allergic rhinitis.
    Clin Exp Allergy. 2021;51:821-828.
    PubMed     Abstract available
    
    
    
54. TVERSKY J, Lane AP, Azar A
    Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double-blind placebo-controlled trial.
    Clin Exp Allergy. 2021;51:836-844.
    PubMed     Abstract available
    
    
    
55. BALLARDINI N, Bergstrom A, Kull I, Almqvist C, et al
    Resolved allergen-specific IgE sensitization among females and early poly-sensitization among males impact IgE sensitization up to age 24 years.
    Clin Exp Allergy. 2021;51:849-852.
    PubMed    
    
    
    
56. WRAITH DC, Krishna MT
    Peptide allergen-specific immunotherapy for allergic airway diseases-State of the art.
    Clin Exp Allergy. 2021;51:751-769.
    PubMed     Abstract available
    
    
    
57. HACCURIA A, Van Muylem A, Malinovschi A, Rasschaert J, et al
    Increased expression of IL-33 is found in the lower airways of patients with seasonal allergic rhinitis and is not related to natural allergen exposure.
    Clin Exp Allergy. 2021;51:845-848.
    PubMed    
    
    
    May 2021
58. BOYLE RJ, Shamji MH
    What does it mean to be food allergic?
    Clin Exp Allergy. 2021;51:634-635.
    PubMed    
    
    
    
59. IDROSE NS, Walters EH, Zhang J, Vicendese D, et al
    Outdoor pollen-related changes in lung function and markers of airway inflammation: A systematic review and meta-analysis.
    Clin Exp Allergy. 2021;51:636-653.
    PubMed     Abstract available
    
    
    April 2021
60. MATTSSON L, Valcour A, Holmqvist M, Larsson H, et al
    Cyclophilin - A novel cross-reactive determinant in peanut.
    Clin Exp Allergy. 2021;51:620-622.
    PubMed    
    
    
    
61. POTAPOVA E, Bauersachs D, Villella V, Meneguzzi G, et al
    Validation study of a new chemiluminescent singleplex IgE assay in a set of Italian allergic rhinitis patients.
    Clin Exp Allergy. 2021;51:604-613.
    PubMed     Abstract available
    
    
    March 2021
62. LOO EXL, Liew TM, Yap GC, Wong LSY, et al
    Trajectories of early-onset rhinitis in the Singapore GUSTO mother-offspring cohort.
    Clin Exp Allergy. 2021;51:419-429.
    PubMed     Abstract available
    
    
    February 2021
63. SHAMJI MH, Boyle RJ
    What does climate change mean for people with pollen allergy?
    Clin Exp Allergy. 2021;51:202-205.
    PubMed    
    
    
    
64. AIROUCHE S, Beltrami V, Fleury S, Batard T, et al
    Bet v 1 contiguous overlapping peptides anchored to virosomes with TLR4 agonist enhance immunotherapy efficacy in mice.
    Clin Exp Allergy. 2021;51:339-349.
    PubMed     Abstract available
    
    
    
65. WURTZEN PA, Gronager PM, Lund G, Gupta S, et al
    Simplified AIT for allergy to several tree pollens-Arguments from the immune outcome analyses following treatment with SQ tree SLIT-tablet.
    Clin Exp Allergy. 2021;51:284-295.
    PubMed     Abstract available
    
    
    
66. ORBAN NT, Jacobson MR, Nouri-Aria KT, Durham SR, et al
    Repetitive nasal allergen challenge in allergic rhinitis: Priming and Th2-type inflammation but no evidence of remodelling.
    Clin Exp Allergy. 2021;51:329-338.
    PubMed     Abstract available
    
    
    January 2021
67. MPAIRWE H, Nkurunungi G, Tumwesige P, Akurut H, et al
    Risk factors associated with rhinitis, allergic conjunctivitis and eczema among schoolchildren in Uganda.
    Clin Exp Allergy. 2021;51:108-119.
    PubMed     Abstract available
    
    
    
68. MARTENS K, Seys SF, Alpizar YA, Schrijvers R, et al
    Staphylococcus aureus enterotoxin B disrupts nasal epithelial barrier integrity.
    Clin Exp Allergy. 2021;51:87-98.
    PubMed     Abstract available
    
    
    
69. FENG Q, Bonnelykke K, Ek WE, Chawes BL, et al
    Null association between serum 25-hydroxyvitamin D levels with allergic rhinitis, allergic sensitization and non-allergic rhinitis: A Mendelian randomization study.
    Clin Exp Allergy. 2021;51:78-86.
    PubMed     Abstract available
    
    
    
70. SUBRAMANIAN A, Adderley NJ, Gkoutos GV, Gokhale KM, et al
    Ethnicity-based differences in the incident risk of allergic diseases and autoimmune disorders: A UK-based retrospective cohort study of 4.4 million participants.
    Clin Exp Allergy. 2021;51:144-147.
    PubMed    
    
    
    October 2020
71. CECCHI L, Scala E, Caronni S, Citterio S, et al
    Allergenicity at component level of subpollens particles from different sources obtained by osmolar shock: a molecular approach to thunderstorm-related asthma outbreaks.
    Clin Exp Allergy. 2020 Oct 18. doi: 10.1111/cea.13764.
    PubMed     Abstract available
    
    
    
72. BLONDAL V, Malinovschi A, Sundbom F, James A, et al
    Multimorbidity in asthma, association with allergy, inflammatory markers and symptom burden, results from the Swedish GA(2) LEN study.
    Clin Exp Allergy. 2020 Oct 14. doi: 10.1111/cea.13759.
    PubMed     Abstract available
    
    
    
73. CONLAN N, Maher GM, Al Khalaf SY, McCarthy FP, et al
    Association between Hypertensive Disorders of Pregnancy and the Risk of Asthma, Eczema and Allergies in Offspring: A Systematic Review and Meta-analysis.
    Clin Exp Allergy. 2020 Oct 9. doi: 10.1111/cea.13754.
    PubMed     Abstract available
    
    
    September 2020
74. DU K, Zheng M, Zhao Y, Xu W, et al
    Impaired small airway function in non-asthmatic chronic rhinosinusitis with nasal polyps.
    Clin Exp Allergy. 2020 Sep 28. doi: 10.1111/cea.13747.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Otorhinolaryngology is free of charge.